| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.774 | 0.004 | 0.827 | Spasmolytic | 0.734 0.005 DBMET00142 0.827 0.004 DBMET00143 0.792 0.004 DBMET01256 0.812 0.004 DBMET01257 | DBMET00143 | |
| 0.602 | 0.004 | 0.602 | Anesthetic local | 0.518 0.004 DBMET00142 0.589 0.004 DBMET00143 0.507 0.004 DBMET01256 0.58 0.004 DBMET01257 | ||
| 0.488 | 0.017 | 0.635 | Vasodilator, coronary | 0.564 0.009 DBMET00142 0.545 0.011 DBMET00143 0.635 0.006 DBMET01256 0.554 0.01 DBMET01257 | DBMET01256 | |
| 0.483 | 0.035 | 0.665 | Cholesterol antagonist | 0.534 0.027 DBMET00142 0.63 0.015 DBMET00143 0.657 0.012 DBMET01256 0.665 0.011 DBMET01257 | DBMET01257 | |
| 0.425 | 0.004 | 0.447 | Acetylcholine muscarinic antagonist | 0.324 0.007 DBMET00142 0.447 0.004 DBMET00143 0.343 0.006 DBMET01256 0.397 0.005 DBMET01257 | DBMET00143 | |
| 0.422 | 0.007 | 0.461 | Cholinergic antagonist | 0.302 0.014 DBMET00142 0.461 0.005 DBMET00143 0.34 0.011 DBMET01256 0.377 0.009 DBMET01257 | DBMET00143 | |
| 0.416 | 0.007 | 0.457 | Acetylcholine antagonist | 0.293 0.014 DBMET00142 0.457 0.005 DBMET00143 0.333 0.011 DBMET01256 0.367 0.009 DBMET01257 | DBMET00143 | |
| 0.412 | 0.027 | 0.412 | Cardiotonic | 0.341 0.042 DBMET00142 0.386 0.031 DBMET00143 0.323 0.047 DBMET01256 0.394 0.03 DBMET01257 | ||
| 0.396 | 0.023 | 0.441 | Sigma receptor agonist | 0.376 0.026 DBMET00142 0.263 0.046 DBMET00143 0.242 0.05 DBMET01256 0.441 0.016 DBMET01257 | DBMET01257 | |
| 0.387 | 0.029 | 0.387 | Potassium channel (Voltage-sensitive) blocker | 0.158 0.13 DBMET00142 0.276 0.057 DBMET00143 0.183 0.108 DBMET01257 | ||
| 0.408 | 0.057 | 0.456 | Toll-Like receptor 7 agonist | 0.27 0.131 DBMET00142 0.456 0.042 DBMET00143 0.332 0.091 DBMET01256 0.453 0.043 DBMET01257 | DBMET00143 | |
| 0.408 | 0.057 | 0.465 | Toll-Like receptor agonist | 0.268 0.133 DBMET00142 0.465 0.039 DBMET00143 0.339 0.087 DBMET01256 0.451 0.043 DBMET01257 | DBMET00143 | |
| 0.403 | 0.063 | 0.542 | Transcription factor NF kappa B inhibitor | 0.51 0.043 DBMET00142 0.434 0.056 DBMET00143 0.542 0.038 DBMET01256 0.44 0.055 DBMET01257 | DBMET01256 | |
| 0.4 | 0.062 | 0.428 | Calpain 2 inhibitor | 0.428 0.047 DBMET00142 0.355 0.084 DBMET00143 0.392 0.066 DBMET01256 0.341 0.091 DBMET01257 | DBMET00142 | |
| 0.36 | 0.023 | 0.453 | 5 Hydroxytryptamine uptake stimulant | 0.426 0.01 DBMET00142 0.352 0.025 DBMET00143 0.417 0.011 DBMET01256 0.453 0.007 DBMET01257 | DBMET01257 | |
| 0.338 | 0.004 | 0.371 | Acetylcholine M3 receptor antagonist | 0.254 0.005 DBMET00142 0.371 0.003 DBMET00143 0.291 0.004 DBMET01256 0.321 0.004 DBMET01257 | DBMET00143 | |
| 0.327 | 0.01 | 0.327 | Acetylcholine M1 receptor antagonist | 0.271 0.02 DBMET00142 0.322 0.011 DBMET00143 0.267 0.021 DBMET01256 0.324 0.011 DBMET01257 | ||
| 0.335 | 0.02 | 0.337 | Ca(v)3.3 blocker | 0.337 0.019 DBMET00142 0.296 0.046 DBMET00143 0.3 0.042 DBMET01256 0.288 0.053 DBMET01257 | DBMET00142 | |
| 0.323 | 0.025 | 0.323 | P-glycoprotein inhibitor | 0.168 0.092 DBMET00142 0.294 0.03 DBMET00143 0.161 0.1 DBMET01256 0.311 0.027 DBMET01257 | ||
| 0.305 | 0.008 | 0.316 | Nav1.1 sodium channel blocker | 0.316 0.007 DBMET00142 0.293 0.009 DBMET00143 0.305 0.008 DBMET01256 0.244 0.013 DBMET01257 | DBMET00142 | |
| 0.333 | 0.038 | 0.446 | Vasodilator | 0.424 0.019 DBMET00142 0.361 0.03 DBMET00143 0.446 0.017 DBMET01256 0.354 0.032 DBMET01257 | DBMET01256 | |
| 0.35 | 0.057 | 0.455 | 12-Lipoxygenase inhibitor | 0.455 0.028 DBMET00142 0.279 0.093 DBMET00143 0.37 0.049 DBMET01256 0.29 0.085 DBMET01257 | DBMET00142 | |
| 0.295 | 0.005 | 0.295 | Ca(v)2.2 blocker | 0.278 0.007 DBMET00142 0.245 0.01 DBMET00143 0.228 0.012 DBMET01256 0.245 0.01 DBMET01257 | ||
| 0.293 | 0.004 | 0.499 | Adrenaline agonist | 0.366 0.003 DBMET00142 0.404 0.003 DBMET00143 0.499 0.002 DBMET01256 0.335 0.003 DBMET01257 | DBMET01256 | |
| 0.344 | 0.058 | 0.609 | 5 Hydroxytryptamine release stimulant | 0.592 0.015 DBMET00142 0.368 0.052 DBMET00143 0.609 0.014 DBMET01256 0.209 0.114 DBMET01257 | DBMET01256 | |
| 0.297 | 0.01 | 0.308 | Calcium channel blocker | 0.242 0.018 DBMET00142 0.255 0.016 DBMET00143 0.203 0.029 DBMET01256 0.308 0.009 DBMET01257 | DBMET01257 | |
| 0.309 | 0.031 | 0.336 | Anesthetic general | 0.261 0.046 DBMET00142 0.275 0.04 DBMET00143 0.232 0.058 DBMET01256 0.336 0.026 DBMET01257 | DBMET01257 | |
| 0.31 | 0.04 | 0.498 | Psychostimulant | 0.498 0.011 DBMET00142 0.288 0.046 DBMET00143 0.48 0.013 DBMET01256 0.258 0.055 DBMET01257 | DBMET00142 | |
| 0.329 | 0.065 | 0.339 | Calcium channel activator | 0.339 0.057 DBMET00142 0.313 0.079 DBMET00143 0.324 0.07 DBMET01256 0.303 0.088 DBMET01257 | DBMET00142 | |
| 0.315 | 0.062 | 0.552 | Aldehyde oxidase inhibitor | 0.176 0.119 DBMET00142 0.22 0.095 DBMET00143 0.552 0.025 DBMET01257 | DBMET01257 | |
| 0.358 | 0.108 | 0.452 | 5 Hydroxytryptamine release inhibitor | 0.364 0.104 DBMET00142 0.257 0.218 DBMET00143 0.262 0.212 DBMET01256 0.452 0.05 DBMET01257 | DBMET01257 | |
| 0.286 | 0.04 | 0.286 | 5 Hydroxytryptamine 1E antagonist | 0.236 0.091 DBMET00142 0.176 0.159 DBMET01257 | ||
| 0.295 | 0.05 | 0.295 | HERG channel blocker | 0.207 0.086 DBMET00143 | ||
| 0.262 | 0.02 | 0.3 | Nav1.2 sodium channel blocker | 0.3 0.015 DBMET00142 0.191 0.038 DBMET00143 0.217 0.029 DBMET01256 0.144 0.061 DBMET01257 | DBMET00142 | |
| 0.244 | 0.011 | 0.248 | Calcium channel (voltage-sensitive) blocker | 0.201 0.017 DBMET00142 0.192 0.019 DBMET00143 0.161 0.029 DBMET01256 0.248 0.01 DBMET01257 | DBMET01257 | |
| 0.317 | 0.089 | 0.472 | Vasodilator, peripheral | 0.4 0.055 DBMET00142 0.393 0.057 DBMET00143 0.472 0.034 DBMET01256 0.399 0.055 DBMET01257 | DBMET01256 | |
| 0.271 | 0.05 | 0.28 | Tyrosine 3 hydroxylase inhibitor | 0.28 0.044 DBMET00142 0.247 0.071 DBMET00143 0.255 0.063 DBMET01256 0.261 0.058 DBMET01257 | DBMET00142 | |
| 0.261 | 0.047 | 0.276 | Neuropeptide Y2 antagonist | 0.276 0.034 DBMET00142 0.228 0.079 DBMET00143 0.249 0.057 DBMET01256 0.235 0.072 DBMET01257 | DBMET00142 | |
| 0.271 | 0.057 | 0.271 | Potassium channel blocker | 0.172 0.114 DBMET00143 | ||
| 0.248 | 0.039 | 0.258 | Neurotrophic factor enhancer | 0.236 0.047 DBMET00142 0.258 0.034 DBMET00143 0.246 0.041 DBMET01256 0.174 0.106 DBMET01257 | DBMET00143 | |
| 0.284 | 0.079 | 0.301 | Lipoxygenase inhibitor | 0.289 0.077 DBMET00142 0.296 0.073 DBMET00143 0.301 0.071 DBMET01256 0.283 0.08 DBMET01257 | DBMET01256 | |
| 0.212 | 0.014 | 0.228 | Calcium channel N-type blocker | 0.228 0.011 DBMET00142 0.176 0.024 DBMET00143 0.189 0.019 DBMET01256 0.191 0.019 DBMET01257 | DBMET00142 | |
| 0.252 | 0.057 | 0.252 | Amyloid beta aggregation inhibitor | 0.149 0.109 DBMET00142 0.223 0.067 DBMET00143 0.135 0.12 DBMET01256 0.223 0.067 DBMET01257 | ||
| 0.253 | 0.062 | 0.278 | Calpain inhibitor | 0.278 0.042 DBMET00142 0.242 0.073 DBMET00143 0.269 0.049 DBMET01256 0.229 0.085 DBMET01257 | DBMET00142 | |
| 0.254 | 0.067 | 0.269 | Free radical scavenger | 0.211 0.089 DBMET00142 0.252 0.068 DBMET00143 0.212 0.088 DBMET01256 0.269 0.061 DBMET01257 | DBMET01257 | |
| 0.194 | 0.015 | 0.287 | NMDA receptor antagonist | 0.236 0.01 DBMET00142 0.132 0.03 DBMET00143 0.16 0.021 DBMET01256 0.287 0.007 DBMET01257 | DBMET01257 | |
| 0.256 | 0.08 | 0.283 | Antioxidant | 0.252 0.082 DBMET00142 0.283 0.068 DBMET00143 0.278 0.071 DBMET01256 0.265 0.076 DBMET01257 | DBMET00143 | |
| 0.176 | 0.007 | 0.216 | Calcium channel L-type blocker | 0.148 0.01 DBMET00142 0.157 0.009 DBMET00143 0.13 0.014 DBMET01256 0.216 0.005 DBMET01257 | DBMET01257 | |
| 0.295 | 0.135 | 0.295 | 15-Lipoxygenase inhibitor | 0.265 0.153 DBMET00142 0.25 0.164 DBMET01257 | ||
| 0.189 | 0.029 | 0.234 | Nav1.3 sodium channel blocker | 0.234 0.016 DBMET00142 0.179 0.032 DBMET00143 0.221 0.019 DBMET01256 0.156 0.044 DBMET01257 | DBMET00142 | |
| 0.2 | 0.041 | 0.211 | Melanin inhibitor | 0.211 0.037 DBMET00142 0.176 0.054 DBMET00143 0.184 0.049 DBMET01256 0.177 0.053 DBMET01257 | DBMET00142 | |
| 0.154 | 0.003 | 0.307 | Beta 2 adrenoreceptor agonist | 0.185 0.002 DBMET00142 0.26 0.002 DBMET00143 0.307 0.001 DBMET01256 0.155 0.003 DBMET01257 | DBMET01256 | |
| 0.164 | 0.013 | 0.164 | Acetylcholine M3 receptor agonist | 0.102 0.044 DBMET00142 0.141 0.024 DBMET00143 0.14 0.024 DBMET01257 | ||
| 0.18 | 0.03 | 0.25 | Neuropeptide Y1 antagonist | 0.25 0.008 DBMET00142 0.157 0.054 DBMET00143 0.216 0.014 DBMET01256 0.165 0.045 DBMET01257 | DBMET00142 | |
| 0.24 | 0.092 | 0.253 | Gastrin inhibitor | 0.242 0.088 DBMET00142 0.188 0.166 DBMET00143 0.192 0.161 DBMET01256 0.253 0.075 DBMET01257 | DBMET01257 | |
| 0.175 | 0.031 | 0.175 | Nav1.6 sodium channel blocker | 0.158 0.045 DBMET00142 0.161 0.043 DBMET00143 0.144 0.061 DBMET01256 0.126 0.087 DBMET01257 | ||
| 0.261 | 0.117 | 0.369 | Sodium/bile acid cotransporter inhibitor | 0.369 0.029 DBMET00142 0.252 0.126 DBMET00143 0.361 0.033 DBMET01256 0.323 0.059 DBMET01257 | DBMET00142 | |
| 0.146 | 0.008 | 0.146 | Acetylcholine M5 receptor antagonist | 0.076 0.027 DBMET00142 0.135 0.01 DBMET00143 0.07 0.031 DBMET01256 0.099 0.018 DBMET01257 | ||
| 0.186 | 0.048 | 0.207 | Lipid peroxidase inhibitor | 0.207 0.039 DBMET00142 0.186 0.048 DBMET00143 0.206 0.039 DBMET01256 0.169 0.056 DBMET01257 | DBMET00142 | |
| 0.148 | 0.015 | 0.156 | Histamine N-methyltransferase inhibitor | 0.126 0.025 DBMET00142 0.103 0.043 DBMET00143 0.077 0.07 DBMET01256 0.156 0.012 DBMET01257 | DBMET01257 | |
| 0.16 | 0.029 | 0.171 | Vanilloid 1 agonist | 0.168 0.024 DBMET00142 0.163 0.027 DBMET00143 0.171 0.023 DBMET01256 0.135 0.058 DBMET01257 | DBMET01256 | |
| 0.153 | 0.023 | 0.232 | Sphingomyelinase inhibitor | 0.173 0.016 DBMET00142 0.213 0.007 DBMET00143 0.232 0.005 DBMET01256 0.137 0.031 DBMET01257 | DBMET01256 | |
| 0.17 | 0.044 | 0.192 | Neurotrophic factor | 0.13 0.081 DBMET00142 0.19 0.032 DBMET00143 0.151 0.058 DBMET01256 0.192 0.031 DBMET01257 | DBMET01257 | |
| 0.249 | 0.128 | 0.329 | Apoptosis antagonist | 0.271 0.108 DBMET00142 0.315 0.076 DBMET00143 0.329 0.067 DBMET01256 0.291 0.091 DBMET01257 | DBMET01256 | |
| 0.233 | 0.113 | 0.279 | Insulysin inhibitor | 0.243 0.103 DBMET00142 0.279 0.073 DBMET01257 | DBMET01257 | |
| 0.264 | 0.145 | 0.472 | Histamine release inhibitor | 0.226 0.175 DBMET00142 0.213 0.188 DBMET00143 0.472 0.04 DBMET01257 | DBMET01257 | |
| 0.133 | 0.014 | 0.133 | Acetylcholine M2 receptor antagonist | 0.087 0.025 DBMET00142 0.109 0.019 DBMET00143 0.074 0.034 DBMET01256 0.105 0.02 DBMET01257 | ||
| 0.156 | 0.038 | 0.231 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET00142 0.106 0.07 DBMET00143 0.231 0.018 DBMET01257 | DBMET01257 | |
| 0.127 | 0.009 | 0.216 | Beta adrenoreceptor antagonist | 0.181 0.004 DBMET00142 0.148 0.006 DBMET00143 0.216 0.004 DBMET01256 0.119 0.01 DBMET01257 | DBMET01256 | |
| 0.132 | 0.014 | 0.132 | Acetylcholine M4 receptor antagonist | 0.074 0.053 DBMET00142 0.129 0.015 DBMET00143 0.072 0.055 DBMET01256 0.099 0.029 DBMET01257 | ||
| 0.161 | 0.046 | 0.209 | Adenylate cyclase stimulant | 0.203 0.012 DBMET00142 0.165 0.041 DBMET00143 0.209 0.01 DBMET01256 0.137 0.088 DBMET01257 | DBMET01256 | |
| 0.19 | 0.08 | 0.19 | 5 Hydroxytryptamine 3E antagonist | 0.163 0.162 DBMET00143 | ||
| 0.116 | 0.01 | 0.116 | CC chemokine 5 receptor agonist | 0.109 0.014 DBMET00142 0.082 0.059 DBMET00143 0.077 0.075 DBMET01256 0.077 0.075 DBMET01257 | ||
| 0.104 | 0.004 | 0.364 | Beta adrenoreceptor agonist | 0.164 0.003 DBMET00142 0.239 0.002 DBMET00143 0.364 0.002 DBMET01256 0.17 0.003 DBMET01257 | DBMET01256 | |
| 0.117 | 0.023 | 0.135 | Histamine H2 receptor antagonist | 0.135 0.014 DBMET00142 0.094 0.041 DBMET00143 0.109 0.027 DBMET01256 0.107 0.029 DBMET01257 | DBMET00142 | |
| 0.133 | 0.038 | 0.328 | Bronchodilator | 0.252 0.013 DBMET00142 0.227 0.015 DBMET00143 0.328 0.008 DBMET01256 0.122 0.043 DBMET01257 | DBMET01256 | |
| 0.125 | 0.032 | 0.138 | Calcium antagonist | 0.138 0.026 DBMET00142 0.102 0.046 DBMET00143 0.114 0.038 DBMET01256 0.127 0.031 DBMET01257 | DBMET00142 | |
| 0.13 | 0.038 | 0.13 | Estrogen antagonist | 0.108 0.078 DBMET00142 0.121 0.053 DBMET00143 0.12 0.056 DBMET01257 | ||
| 0.093 | 0.009 | 0.16 | Beta 2 adrenoreceptor antagonist | 0.143 0.005 DBMET00142 0.112 0.007 DBMET00143 0.16 0.004 DBMET01256 0.079 0.012 DBMET01257 | DBMET01256 | |
| 0.104 | 0.02 | 0.104 | Estrogen-related receptor beta agonist | 0.103 0.021 DBMET00142 0.086 0.05 DBMET00143 0.085 0.052 DBMET01256 0.086 0.049 DBMET01257 | ||
| 0.117 | 0.035 | 0.117 | Estrogen receptor beta antagonist | 0.093 0.077 DBMET00142 0.108 0.05 DBMET00143 0.107 0.051 DBMET01257 | ||
| 0.143 | 0.062 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.134 0.098 DBMET00142 0.132 0.11 DBMET00143 0.157 0.028 DBMET01257 | DBMET01257 | |
| 0.162 | 0.082 | 0.185 | ATPase inhibitor | 0.185 0.051 DBMET00142 | DBMET00142 | |
| 0.257 | 0.177 | 0.257 | Analgesic | 0.226 0.208 DBMET00143 0.245 0.187 DBMET01257 | ||
| 0.188 | 0.108 | 0.253 | Antiamyloidogenic | 0.159 0.135 DBMET00142 0.198 0.101 DBMET00143 0.167 0.126 DBMET01256 0.253 0.07 DBMET01257 | DBMET01257 | |
| 0.207 | 0.128 | 0.241 | Transcription factor STAT inhibitor | 0.241 0.093 DBMET00142 0.201 0.137 DBMET01256 0.213 0.12 DBMET01257 | DBMET00142 | |
| 0.124 | 0.048 | 0.191 | Expectorant | 0.142 0.039 DBMET00142 0.165 0.03 DBMET00143 0.186 0.024 DBMET01256 0.191 0.022 DBMET01257 | DBMET01257 | |
| 0.118 | 0.042 | 0.164 | Creatine kinase inhibitor | 0.128 0.036 DBMET00142 0.089 0.073 DBMET01256 0.164 0.019 DBMET01257 | DBMET01257 | |
| 0.136 | 0.061 | 0.153 | Glutamate receptor antagonist | 0.124 0.07 DBMET00142 0.153 0.049 DBMET01257 | DBMET01257 | |
| 0.196 | 0.122 | 0.331 | Superoxide dismutase inhibitor | 0.228 0.09 DBMET00142 0.19 0.129 DBMET01256 0.331 0.041 DBMET01257 | DBMET01257 | |
| 0.125 | 0.052 | 0.138 | Transcription factor STAT6 inhibitor | 0.138 0.035 DBMET00142 | DBMET00142 | |
| 0.131 | 0.058 | 0.139 | Papain-like protease (SARS coronavirus) inhibitor | 0.139 0.046 DBMET00142 0.118 0.087 DBMET01256 0.115 0.094 DBMET01257 | DBMET00142 | |
| 0.12 | 0.048 | 0.12 | Acetylcholine release stimulant | 0.109 0.068 DBMET00143 0.099 0.09 DBMET01257 | ||
| 0.101 | 0.033 | 0.187 | Myeloperoxidase inhibitor | 0.149 0.011 DBMET00142 0.12 0.02 DBMET00143 0.187 0.006 DBMET01256 0.095 0.041 DBMET01257 | DBMET01256 | |
| 0.071 | 0.004 | 0.08 | Glutamate (mGluR8) antagonist | 0.068 0.004 DBMET00142 0.066 0.004 DBMET00143 0.063 0.005 DBMET01256 0.08 0.003 DBMET01257 | DBMET01257 | |
| 0.158 | 0.092 | 0.221 | Phospholipase C inhibitor | 0.178 0.063 DBMET00142 0.191 0.05 DBMET00143 0.221 0.033 DBMET01256 0.192 0.05 DBMET01257 | DBMET01256 | |
| 0.14 | 0.075 | 0.194 | Protein kinase stimulant | 0.136 0.079 DBMET00142 0.194 0.044 DBMET00143 0.189 0.046 DBMET01256 0.131 0.083 DBMET01257 | DBMET00143 | |
| 0.096 | 0.033 | 0.096 | Analgesic, opioid | 0.07 0.061 DBMET00142 0.079 0.049 DBMET00143 0.085 0.042 DBMET01257 | ||
| 0.119 | 0.056 | 0.119 | Nav1.5 sodium channel blocker | 0.115 0.061 DBMET00142 0.102 0.081 DBMET00143 0.099 0.088 DBMET01256 | ||
| 0.094 | 0.031 | 0.094 | Estrogen receptor alpha antagonist | 0.078 0.052 DBMET00143 0.074 0.06 DBMET01257 | ||
| 0.107 | 0.045 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.12 0.03 DBMET00143 0.094 0.065 DBMET01256 0.087 0.077 DBMET01257 | DBMET00143 | |
| 0.118 | 0.057 | 0.173 | Mucolytic | 0.135 0.042 DBMET00142 0.155 0.03 DBMET00143 0.173 0.021 DBMET01256 0.165 0.024 DBMET01257 | DBMET01256 | |
| 0.226 | 0.17 | 0.25 | Immunosuppressant | 0.25 0.148 DBMET00143 0.218 0.178 DBMET01256 0.248 0.149 DBMET01257 | DBMET00143 | |
| 0.111 | 0.057 | 0.178 | Mediator release inhibitor | 0.164 0.023 DBMET00142 0.116 0.051 DBMET00143 0.172 0.021 DBMET01256 0.178 0.019 DBMET01257 | DBMET01257 | |
| 0.08 | 0.025 | 0.147 | Purinergic P2X1 antagonist | 0.091 0.02 DBMET00143 0.147 0.007 DBMET01257 | DBMET01257 | |
| 0.081 | 0.027 | 0.081 | Glutamate (mGluR7) antagonist | 0.062 0.059 DBMET00142 0.075 0.034 DBMET01257 | ||
| 0.159 | 0.105 | 0.206 | Non-steroidal antiinflammatory agent | 0.165 0.099 DBMET00143 0.206 0.066 DBMET01257 | DBMET01257 | |
| 0.112 | 0.06 | 0.123 | Falcipain 3 inhibitor | 0.093 0.077 DBMET00142 0.12 0.054 DBMET00143 0.101 0.069 DBMET01256 0.123 0.052 DBMET01257 | DBMET01257 | |
| 0.093 | 0.043 | 0.093 | Opioid kappa receptor antagonist | 0.076 0.064 DBMET00142 0.078 0.061 DBMET00143 0.074 0.069 DBMET01257 | ||
| 0.076 | 0.027 | 0.078 | Dopamine uptake inhibitor | 0.078 0.026 DBMET00142 0.057 0.041 DBMET00143 0.058 0.04 DBMET01256 0.053 0.045 DBMET01257 | DBMET00142 | |
| 0.085 | 0.038 | 0.124 | Aminopeptidase I inhibitor | 0.103 0.027 DBMET00142 0.068 0.056 DBMET00143 0.084 0.039 DBMET01256 0.124 0.018 DBMET01257 | DBMET01257 | |
| 0.064 | 0.019 | 0.064 | Vanilloid 2 antagonist | 0.058 0.025 DBMET00143 0.054 0.032 DBMET01257 | ||
| 0.213 | 0.168 | 0.354 | Interleukin 2 agonist | 0.257 0.111 DBMET00142 0.328 0.056 DBMET00143 0.354 0.044 DBMET01256 0.247 0.122 DBMET01257 | DBMET01256 | |
| 0.087 | 0.042 | 0.235 | Porphobilinogen synthase inhibitor | 0.066 0.06 DBMET00142 0.131 0.025 DBMET00143 0.098 0.037 DBMET01256 0.235 0.009 DBMET01257 | DBMET01257 | |
| 0.11 | 0.067 | 0.11 | Alpha 2b adrenoreceptor antagonist | 0.101 0.073 DBMET00142 | ||
| 0.09 | 0.047 | 0.117 | Glutathione S-transferase inhibitor | 0.117 0.024 DBMET00142 0.083 0.056 DBMET00143 0.109 0.03 DBMET01256 0.103 0.034 DBMET01257 | DBMET00142 | |
| 0.069 | 0.027 | 0.069 | Heme oxygenase stimulant | 0.068 0.028 DBMET00142 0.058 0.054 DBMET00143 0.057 0.054 DBMET01256 0.066 0.031 DBMET01257 | ||
| 0.073 | 0.034 | 0.101 | Glutamate (mGluR6) antagonist | 0.07 0.039 DBMET00142 0.072 0.035 DBMET00143 0.07 0.04 DBMET01256 0.101 0.01 DBMET01257 | DBMET01257 | |
| 0.132 | 0.093 | 0.196 | Diuretic | 0.12 0.104 DBMET00142 0.196 0.046 DBMET01257 | DBMET01257 | |
| 0.092 | 0.054 | 0.092 | Opioid antagonist | 0.087 0.06 DBMET00142 0.078 0.071 DBMET00143 | ||
| 0.135 | 0.098 | 0.148 | Heat shock protein 70 antagonist | 0.133 0.106 DBMET00142 0.148 0.05 DBMET01257 | DBMET01257 | |
| 0.106 | 0.069 | 0.182 | Chelator | 0.144 0.038 DBMET00142 0.127 0.047 DBMET00143 0.182 0.028 DBMET01256 0.139 0.04 DBMET01257 | DBMET01256 | |
| 0.061 | 0.025 | 0.11 | Alpha-mannosidase inhibitor | 0.072 0.016 DBMET00142 0.09 0.008 DBMET00143 0.11 0.005 DBMET01256 0.067 0.019 DBMET01257 | DBMET01256 | |
| 0.136 | 0.1 | 0.143 | Interferon gamma antagonist | 0.125 0.122 DBMET00142 0.143 0.088 DBMET01257 | DBMET01257 | |
| 0.099 | 0.065 | 0.165 | Aminopeptidase B inhibitor | 0.133 0.045 DBMET00142 0.114 0.056 DBMET01256 0.165 0.032 DBMET01257 | DBMET01257 | |
| 0.069 | 0.035 | 0.081 | Adrenaline uptake inhibitor | 0.081 0.026 DBMET00142 0.056 0.049 DBMET00143 0.068 0.036 DBMET01256 | DBMET00142 | |
| 0.041 | 0.007 | 0.085 | Calcium-sensing receptor agonist | 0.046 0.006 DBMET00142 0.037 0.009 DBMET00143 0.041 0.007 DBMET01256 0.085 0.004 DBMET01257 | DBMET01257 | |
| 0.08 | 0.051 | 0.102 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.102 0.036 DBMET00143 0.082 0.05 DBMET01256 0.097 0.039 DBMET01257 | DBMET00143 | |
| 0.174 | 0.145 | 0.174 | RNA-directed DNA polymerase inhibitor | 0.166 0.161 DBMET00143 | ||
| 0.036 | 0.008 | 0.036 | Estrogen-related receptor gamma antagonist | 0.027 0.023 DBMET00142 0.028 0.019 DBMET00143 | ||
| 0.134 | 0.107 | 0.138 | Arachidonic acid antagonist | 0.138 0.102 DBMET01257 | DBMET01257 | |
| 0.067 | 0.04 | 0.067 | 5 Hydroxytryptamine 2A agonist | |||
| 0.035 | 0.009 | 0.039 | Thyroid hormone agonist | 0.038 0.007 DBMET00142 0.036 0.008 DBMET00143 0.039 0.006 DBMET01256 0.029 0.013 DBMET01257 | DBMET01256 | |
| 0.065 | 0.039 | 0.065 | Calcium channel P-type blocker | 0.061 0.056 DBMET00142 | ||
| 0.091 | 0.065 | 0.122 | Prolactin inhibitor | 0.122 0.037 DBMET00143 0.088 0.07 DBMET01256 0.082 0.078 DBMET01257 | DBMET00143 | |
| 0.193 | 0.168 | 0.193 | Thyroid hormone antagonist | |||
| 0.05 | 0.025 | 0.086 | NMDA receptor subunit 3B antagonist | 0.041 0.034 DBMET00142 0.086 0.013 DBMET01257 | DBMET01257 | |
| 0.069 | 0.046 | 0.115 | Alpha adrenoreceptor agonist | 0.115 0.023 DBMET00142 0.074 0.042 DBMET01256 | DBMET00142 | |
| 0.133 | 0.111 | 0.134 | CF transmembrane conductance regulator agonist | 0.134 0.108 DBMET00143 | DBMET00143 | |
| 0.122 | 0.1 | 0.13 | Farnesoid X receptor antagonist | 0.116 0.113 DBMET00142 0.13 0.082 DBMET01257 | DBMET01257 | |
| 0.035 | 0.016 | 0.055 | Glutamate (mGluR3) agonist | 0.037 0.014 DBMET00142 0.032 0.022 DBMET00143 0.034 0.019 DBMET01256 0.055 0.004 DBMET01257 | DBMET01257 | |
| 0.103 | 0.083 | 0.126 | Proteasome inhibitor | 0.126 0.06 DBMET00142 0.103 0.083 DBMET00143 0.126 0.06 DBMET01256 | DBMET01256 | |
| 0.091 | 0.071 | 0.105 | Bile acid receptor antagonist | 0.103 0.043 DBMET00142 0.096 0.058 DBMET01256 0.105 0.038 DBMET01257 | DBMET01257 | |
| 0.068 | 0.049 | 0.129 | Phosphofructokinase-1 inhibitor | 0.07 0.048 DBMET00142 0.106 0.03 DBMET00143 0.108 0.029 DBMET01256 0.129 0.023 DBMET01257 | DBMET01257 | |
| 0.024 | 0.005 | 0.024 | Thyroid hormone alpha agonist | 0.022 0.005 DBMET00142 0.022 0.006 DBMET00143 0.02 0.007 DBMET01256 0.021 0.006 DBMET01257 | ||
| 0.032 | 0.013 | 0.044 | Epoxide hydrolase 2 inhibitor | 0.044 0.007 DBMET00142 0.035 0.011 DBMET01256 0.027 0.015 DBMET01257 | DBMET00142 | |
| 0.053 | 0.036 | 0.053 | Opioid agonist | |||
| 0.168 | 0.151 | 0.211 | Peptidyltransferase inhibitor | 0.211 0.086 DBMET00142 0.164 0.159 DBMET00143 0.205 0.093 DBMET01256 0.187 0.118 DBMET01257 | DBMET00142 | |
| 0.051 | 0.034 | 0.056 | Prolyl endopeptidase inhibitor | 0.056 0.028 DBMET00143 0.056 0.028 DBMET01257 | DBMET01257 | |
| 0.066 | 0.049 | 0.066 | Opioid mu receptor antagonist | 0.063 0.051 DBMET00142 | ||
| 0.155 | 0.138 | 0.179 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.164 0.118 DBMET00143 0.179 0.094 DBMET01257 | DBMET01257 | |
| 0.142 | 0.127 | 0.223 | Succinate dehydrogenase inhibitor | 0.147 0.117 DBMET00142 0.14 0.133 DBMET01256 0.223 0.034 DBMET01257 | DBMET01257 | |
| 0.083 | 0.068 | 0.135 | NADH dehydrogenase inhibitor | 0.099 0.045 DBMET00143 0.135 0.022 DBMET01257 | DBMET01257 | |
| 0.046 | 0.031 | 0.098 | Mannosidase inhibitor | 0.057 0.019 DBMET00142 0.078 0.009 DBMET00143 0.098 0.006 DBMET01256 0.063 0.015 DBMET01257 | DBMET01256 | |
| 0.042 | 0.027 | 0.049 | Plasmepsin II inhibitor | 0.049 0.018 DBMET00143 0.042 0.027 DBMET01256 | DBMET00143 | |
| 0.126 | 0.111 | 0.204 | Growth hormone agonist | 0.17 0.073 DBMET00142 0.158 0.081 DBMET00143 0.204 0.057 DBMET01256 0.123 0.116 DBMET01257 | DBMET01256 | |
| 0.063 | 0.048 | 0.119 | Beta 3 adrenoreceptor antagonist | 0.109 0.012 DBMET00142 0.067 0.039 DBMET00143 0.119 0.01 DBMET01256 0.061 0.054 DBMET01257 | DBMET01256 | |
| 0.1 | 0.087 | 0.13 | Cholesterol synthesis inhibitor | 0.13 0.057 DBMET01257 | DBMET01257 | |
| 0.038 | 0.024 | 0.074 | Glutamate (mGluR3) antagonist | 0.035 0.027 DBMET00142 0.043 0.017 DBMET00143 0.041 0.02 DBMET01256 0.074 0.005 DBMET01257 | DBMET01257 | |
| 0.041 | 0.028 | 0.043 | Acetyl-CoA transferase 1 inhibitor | 0.043 0.025 DBMET00142 | DBMET00142 | |
| 0.055 | 0.043 | 0.059 | Acetyl-CoA transferase 2 inhibitor | 0.059 0.033 DBMET00142 0.056 0.041 DBMET01257 | DBMET00142 | |
| 0.021 | 0.009 | 0.021 | Estrogen-related receptor gamma agonist | 0.02 0.01 DBMET00142 | ||
| 0.051 | 0.04 | 0.052 | Acetyl-CoA transferase inhibitor | 0.052 0.039 DBMET00142 | DBMET00142 | |
| 0.08 | 0.071 | 0.086 | Vanilloid agonist | 0.084 0.06 DBMET00142 0.082 0.064 DBMET00143 0.086 0.055 DBMET01256 | DBMET01256 | |
| 0.193 | 0.186 | 0.368 | Antithrombotic | 0.281 0.102 DBMET00142 0.269 0.112 DBMET00143 0.368 0.058 DBMET01256 0.298 0.089 DBMET01257 | DBMET01256 | |
| 0.156 | 0.149 | 0.334 | Immunostimulant | 0.23 0.105 DBMET00142 0.253 0.095 DBMET00143 0.334 0.069 DBMET01256 0.206 0.116 DBMET01257 | DBMET01256 | |
| 0.039 | 0.033 | 0.058 | Oxytocin agonist | 0.058 0.019 DBMET00142 0.044 0.028 DBMET01256 | DBMET00142 | |
| 0.038 | 0.031 | 0.039 | Dopamine D5 agonist | 0.039 0.03 DBMET00142 | DBMET00142 | |
| 0.084 | 0.077 | 0.094 | 5-Lipoxygenase inhibitor | 0.091 0.071 DBMET00142 0.087 0.074 DBMET00143 0.094 0.068 DBMET01256 0.087 0.074 DBMET01257 | DBMET01256 | |
| 0.04 | 0.035 | 0.054 | Liver X receptor agonist | 0.054 0.02 DBMET00143 0.04 0.036 DBMET01257 | DBMET00143 | |
| 0.127 | 0.123 | 0.167 | Nitric oxide antagonist | 0.14 0.105 DBMET00142 0.152 0.093 DBMET00143 0.167 0.083 DBMET01256 0.133 0.114 DBMET01257 | DBMET01256 | |
| 0.087 | 0.084 | 0.098 | Anabolic | 0.098 0.066 DBMET00142 0.093 0.074 DBMET01256 0.093 0.073 DBMET01257 | DBMET00142 | |
| 0.039 | 0.036 | 0.062 | Histamine H2 receptor agonist | 0.062 0.013 DBMET00142 0.04 0.034 DBMET01256 | DBMET00142 | |
| 0.04 | 0.038 | 0.044 | Glycine transporter 2 inhibitor | 0.044 0.035 DBMET00143 | DBMET00143 | |
| 0.056 | 0.054 | 0.056 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.066 | 0.064 | 0.08 | Glycine receptor agonist | 0.08 0.038 DBMET01257 | DBMET01257 | |
| 0.052 | 0.05 | 0.073 | Adenine nucleotide translocase inhibitor | 0.073 0.013 DBMET01257 | DBMET01257 | |
| 0.079 | 0.078 | 0.106 | Granulocyte macrophage colony stimulating factor agonist | 0.106 0.027 DBMET00143 0.1 0.035 DBMET01256 0.087 0.057 DBMET01257 | DBMET00143 | |
| 0.07 | 0.069 | 0.074 | Acetylcholine nicotinic antagonist | 0.074 0.062 DBMET00143 | DBMET00143 | |
| 0.082 | 0.081 | 0.112 | ABCA1 expression enhancer | 0.112 0.037 DBMET01257 | DBMET01257 | |
| 0.039 | 0.038 | 0.059 | Geranyltranstransferase inhibitor | 0.059 0.014 DBMET00142 0.04 0.038 DBMET01256 | DBMET00142 | |
| 0.037 | 0.037 | 0.041 | CF transmembrane conductance regulator antagonist | 0.041 0.022 DBMET00143 0.039 0.029 DBMET01256 0.039 0.028 DBMET01257 | DBMET00143 | |
| 0.065 | 0.064 | 0.136 | Glutamate dehydrogenase inhibitor | 0.136 0.019 DBMET01257 | DBMET01257 | |
| 0.048 | 0.048 | 0.089 | Leukotriene B4 antagonist | 0.062 0.025 DBMET00143 0.089 0.013 DBMET01257 | DBMET01257 | |
| 0.032 | 0.032 | 0.073 | 5-Alpha-reductase inhibitor | 0.073 0.013 DBMET01257 | DBMET01257 | |
| 0.114 | 0.114 | 0.131 | Sphingosine 1-phosphate receptor 2 antagonist | 0.131 0.071 DBMET00142 0.121 0.094 DBMET01256 0.116 0.108 DBMET01257 | DBMET00142 | |
| 0.053 | 0.053 | 0.062 | Cathepsin E inhibitor | 0.062 0.038 DBMET00142 0.061 0.038 DBMET01256 | DBMET00142 | |
| 0.016 | 0.018 | 0.057 | 5-Alpha-reductase 2 inhibitor | 0.057 0.007 DBMET01257 | DBMET01257 | |
| 0.062 | 0.064 | 0.088 | Cathepsin G inhibitor | 0.069 0.055 DBMET00142 0.079 0.045 DBMET00143 0.088 0.038 DBMET01256 0.072 0.052 DBMET01257 | DBMET01256 | |
| 0.013 | 0.015 | 0.054 | 5-Alpha-reductase 1 inhibitor | 0.054 0.007 DBMET01257 | DBMET01257 | |
| 0.031 | 0.034 | 0.053 | NMDA receptor subunit 3A antagonist | 0.053 0.019 DBMET01257 | DBMET01257 | |
| 0.1 | 0.104 | 0.179 | Toll-Like receptor 2 antagonist | 0.135 0.064 DBMET00142 0.141 0.059 DBMET00143 0.179 0.034 DBMET01256 0.104 0.098 DBMET01257 | DBMET01256 | |
| 0.062 | 0.066 | 0.163 | Glutamate decarboxylase inhibitor | 0.163 0.011 DBMET01257 | DBMET01257 | |
| 0.095 | 0.1 | 0.122 | Caspase 3 inhibitor | 0.099 0.094 DBMET00142 0.102 0.088 DBMET00143 0.106 0.082 DBMET01256 0.122 0.058 DBMET01257 | DBMET01257 | |
| 0.033 | 0.038 | 0.051 | Complement C3a chemotactic receptor antagonist | 0.051 0.026 DBMET00142 0.046 0.029 DBMET01256 | DBMET00142 | |
| 0.023 | 0.028 | 0.053 | Glucagon receptor antagonist | 0.036 0.016 DBMET00142 0.033 0.018 DBMET00143 0.053 0.009 DBMET01256 | DBMET01256 | |
| 0.011 | 0.017 | 0.019 | Adenosine A2a receptor agonist | 0.019 0.008 DBMET00143 0.014 0.011 DBMET01256 | DBMET00143 | |
| 0.067 | 0.073 | 0.084 | Histamine H1 receptor antagonist | 0.084 0.053 DBMET01257 | DBMET01257 | |
| 0.022 | 0.029 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET01257 | DBMET01257 | |
| 0.135 | 0.143 | 0.172 | Neurotensin receptor agonist | 0.172 0.059 DBMET00142 0.154 0.092 DBMET01256 | DBMET00142 | |
| 0.097 | 0.106 | 0.279 | Alpha-N-acetylglucosaminidase inhibitor | 0.108 0.09 DBMET00142 0.154 0.053 DBMET00143 0.171 0.044 DBMET01256 0.279 0.019 DBMET01257 | DBMET01257 | |
| 0.038 | 0.047 | 0.062 | Glutamate (mGluR group III) antagonist | 0.062 0.012 DBMET01257 | DBMET01257 | |
| 0.035 | 0.045 | 0.039 | GHS receptor agonist | 0.039 0.036 DBMET00143 | DBMET00143 | |
| 0.017 | 0.027 | 0.034 | Neuraminidase (Influenza B) inhibitor | 0.034 0.004 DBMET01257 | DBMET01257 | |
| 0.038 | 0.048 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 DBMET00143 0.068 0.008 DBMET01257 | DBMET01257 | |
| 0.011 | 0.023 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 DBMET00143 | DBMET00143 | |
| 0.034 | 0.047 | 0.049 | HIV-1 protease inhibitor | 0.04 0.034 DBMET00142 0.044 0.029 DBMET00143 0.049 0.022 DBMET01256 | DBMET01256 | |
| 0.017 | 0.031 | 0.058 | Beta 1 adrenoreceptor agonist | 0.031 0.008 DBMET00142 0.027 0.01 DBMET00143 0.058 0.004 DBMET01256 0.029 0.009 DBMET01257 | DBMET01256 | |
| 0.044 | 0.059 | 0.083 | Lysine-specific demethylase 1A inhibitor | 0.082 0.011 DBMET00142 0.083 0.011 DBMET01256 | DBMET01256 | |
| 0.1 | 0.116 | 0.135 | Alkaline phosphatase inhibitor | 0.135 0.072 DBMET00142 | DBMET00142 | |
| 0.222 | 0.239 | 0.385 | Calcium channel L-type activator | 0.284 0.171 DBMET00142 0.349 0.118 DBMET00143 0.385 0.091 DBMET01256 0.271 0.184 DBMET01257 | DBMET01256 | |
| 0.117 | 0.134 | 0.142 | Sphingosine 1-phosphate receptor 5 antagonist | 0.142 0.075 DBMET01257 | DBMET01257 | |
| 0.024 | 0.044 | 0.056 | Retinoid X alpha receptor agonist | 0.056 0.012 DBMET01257 | DBMET01257 | |
| 0.102 | 0.122 | 0.12 | Peroxidase inhibitor | 0.12 0.1 DBMET01257 | DBMET01257 | |
| 0.029 | 0.05 | 0.033 | Adenosine uptake inhibitor | 0.033 0.029 DBMET00142 | DBMET00142 | |
| 0.073 | 0.096 | 0.122 | Monophenol monooxygenase inhibitor | 0.107 0.071 DBMET00143 0.122 0.06 DBMET01257 | DBMET01257 | |
| 0.086 | 0.109 | 0.121 | DOPA decarboxylase inhibitor | 0.121 0.044 DBMET01257 | DBMET01257 | |
| 0.045 | 0.069 | 0.079 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.027 DBMET00142 0.054 0.048 DBMET00143 0.079 0.017 DBMET01256 0.06 0.038 DBMET01257 | DBMET01256 | |
| 0.035 | 0.061 | 0.052 | Histamine H1 receptor agonist | 0.052 0.016 DBMET00142 0.041 0.038 DBMET01256 | DBMET00142 | |
| 0.192 | 0.218 | 0.205 | GABA C receptor rho-3 antagonist | 0.205 0.201 DBMET00142 | DBMET00142 | |
| 0.062 | 0.089 | 0.123 | Ornithine decarboxylase inhibitor | 0.093 0.052 DBMET00142 0.083 0.063 DBMET00143 0.109 0.035 DBMET01256 0.123 0.024 DBMET01257 | DBMET01257 | |
| 0.018 | 0.047 | 0.026 | Glutamate (mGluR1) agonist | 0.026 0.015 DBMET00142 0.023 0.021 DBMET01256 | DBMET00142 | |
| 0.037 | 0.067 | 0.049 | Aminopeptidase microsomal inhibitor | 0.049 0.048 DBMET00142 | DBMET00142 | |
| 0.091 | 0.121 | 0.109 | Interleukin 8 antagonist | 0.109 0.078 DBMET00142 | DBMET00142 | |
| 0.028 | 0.058 | 0.044 | Liver X receptor alpha agonist | 0.044 0.025 DBMET00143 | DBMET00143 | |
| 0.053 | 0.087 | 0.091 | Epoxide hydrolase inhibitor | 0.091 0.031 DBMET00142 0.077 0.045 DBMET01256 0.064 0.062 DBMET01257 | DBMET00142 | |
| 0.115 | 0.151 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.098 DBMET01257 | DBMET01257 | |
| 0.026 | 0.063 | 0.044 | GABA uptake inhibitor | 0.044 0.02 DBMET01257 | DBMET01257 | |
| 0.159 | 0.196 | 0.181 | Transcription factor STAT3 inhibitor | 0.181 0.162 DBMET00142 0.18 0.164 DBMET01257 | DBMET00142 | |
| 0.056 | 0.094 | 0.1 | GABA aminotransferase inhibitor | 0.1 0.027 DBMET01257 | DBMET01257 | |
| 0.071 | 0.112 | 0.167 | GABA C receptor agonist | 0.167 0.028 DBMET01257 | DBMET01257 | |
| 0.035 | 0.076 | 0.084 | Beta 1 adrenoreceptor antagonist | 0.076 0.02 DBMET00142 0.084 0.015 DBMET01256 | DBMET01256 | |
| 0.055 | 0.096 | 0.131 | Somatostatin 1 agonist | 0.11 0.028 DBMET00142 0.083 0.048 DBMET00143 0.131 0.019 DBMET01256 0.068 0.067 DBMET01257 | DBMET01256 | |
| 0.048 | 0.089 | 0.066 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 DBMET00143 | DBMET00143 | |
| 0.027 | 0.069 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.021 DBMET01257 | DBMET01257 | |
| 0.068 | 0.11 | 0.128 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.074 DBMET00143 0.128 0.035 DBMET01257 | DBMET01257 | |
| 0.154 | 0.197 | 0.193 | Nitric-oxide synthase stimulant | 0.176 0.137 DBMET00142 0.171 0.151 DBMET00143 0.193 0.101 DBMET01256 | DBMET01256 | |
| 0.004 | 0.048 | 0.013 | Angiotensin AT1B receptor antagonist | 0.013 0.011 DBMET01257 | DBMET01257 | |
| 0.004 | 0.051 | 0.022 | Beta 3 adrenoreceptor agonist | 0.022 0.005 DBMET01256 | DBMET01256 | |
| 0.23 | 0.278 | 0.294 | Caspase 9 stimulant | 0.294 0.201 DBMET00143 | DBMET00143 | |
| 0.033 | 0.083 | 0.067 | Histamine agonist | 0.067 0.021 DBMET00142 | DBMET00142 | |
| 0.042 | 0.094 | 0.089 | Phenylalanine 4-hydroxylase inhibitor | 0.089 0.031 DBMET01257 | DBMET01257 | |
| 0.015 | 0.067 | 0.042 | Retinoid X receptor agonist | 0.042 0.021 DBMET01257 | DBMET01257 | |
| 0.092 | 0.144 | 0.209 | Thrombolytic | 0.189 0.057 DBMET00142 0.125 0.104 DBMET00143 0.209 0.048 DBMET01256 0.149 0.083 DBMET01257 | DBMET01256 | |
| 0.015 | 0.067 | 0.027 | Plasmepsin I inhibitor | 0.027 0.026 DBMET01256 | DBMET01256 | |
| 0.03 | 0.083 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.017 DBMET01257 | DBMET01257 | |
| 0.056 | 0.109 | 0.246 | Antiadrenergic | 0.246 0.018 DBMET00142 0.21 0.023 DBMET01256 | DBMET00142 | |
| 0.039 | 0.095 | 0.072 | Glucosylceramidase inhibitor | 0.055 0.037 DBMET00143 0.072 0.02 DBMET01256 | DBMET01256 | |
| 0.011 | 0.067 | 0.027 | Leukotriene B4 receptor 1 antagonist | 0.027 0.02 DBMET01257 | DBMET01257 | |
| 0.039 | 0.096 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET01257 | DBMET01257 | |
| 0.039 | 0.097 | 0.081 | Leukotriene antagonist | 0.081 0.031 DBMET01257 | DBMET01257 | |
| 0.059 | 0.116 | 0.092 | Neuropeptide Y antagonist | 0.092 0.045 DBMET00142 | DBMET00142 | |
| 0.031 | 0.089 | 0.08 | Argininosuccinate synthase inhibitor | 0.08 0.025 DBMET01257 | DBMET01257 | |
| 0.063 | 0.122 | 0.103 | Triose-phosphate isomerase inhibitor | 0.103 0.045 DBMET01257 | DBMET01257 | |
| 0.027 | 0.089 | 0.05 | Plasminogen activator inhibitor | 0.05 0.048 DBMET01256 | DBMET01256 | |
| 0.023 | 0.086 | 0.06 | Thromboxane A2 antagonist | 0.048 0.038 DBMET00142 0.06 0.028 DBMET01256 0.053 0.033 DBMET01257 | DBMET01256 | |
| 0.007 | 0.07 | 0.026 | Prostaglandin H2 antagonist | 0.026 0.017 DBMET01257 | DBMET01257 | |
| 0.066 | 0.131 | 0.109 | Carbonic anhydrase III inhibitor | 0.109 0.053 DBMET01256 0.095 0.068 DBMET01257 | DBMET01256 | |
| 0.051 | 0.116 | 0.233 | Adrenaline antagonist | 0.233 0.019 DBMET00142 0.2 0.023 DBMET01256 | DBMET00142 | |
| 0.068 | 0.134 | 0.161 | Adenylate cyclase inhibitor | 0.141 0.052 DBMET00142 0.161 0.038 DBMET01256 | DBMET01256 | |
| 0.016 | 0.083 | 0.052 | Kainate receptor antagonist | 0.052 0.02 DBMET01257 | DBMET01257 | |
| 0.063 | 0.13 | 0.118 | UDP-glucose 4-epimerase inhibitor | 0.086 0.079 DBMET00143 0.118 0.044 DBMET01257 | DBMET01257 | |
| 0.056 | 0.124 | 0.073 | Vanilloid 4 agonist | 0.069 0.068 DBMET00142 0.073 0.056 DBMET01256 | DBMET01256 | |
| 0.023 | 0.092 | 0.06 | Ornithine carbamoyltransferase inhibitor | 0.06 0.031 DBMET01257 | DBMET01257 | |
| 0.019 | 0.088 | 0.033 | Angiotensin II receptor antagonist | 0.033 0.026 DBMET01257 | DBMET01257 | |
| 0.042 | 0.113 | 0.062 | Sirtuin 1 inhibitor | 0.06 0.058 DBMET00142 0.062 0.055 DBMET01256 | DBMET01256 | |
| 0.082 | 0.153 | 0.108 | Cathepsin H inhibitor | 0.108 0.093 DBMET00142 | DBMET00142 | |
| 0.042 | 0.113 | 0.089 | Neuraminidase (influenza) inhibitor | 0.089 0.02 DBMET01257 | DBMET01257 | |
| 0.025 | 0.097 | 0.059 | Thromboxane antagonist | 0.047 0.045 DBMET00142 0.059 0.033 DBMET01256 0.055 0.037 DBMET01257 | DBMET01256 | |
| 0.069 | 0.141 | 0.142 | Carbonic anhydrase XV inhibitor | 0.098 0.069 DBMET00142 0.094 0.076 DBMET00143 0.142 0.034 DBMET01256 0.096 0.073 DBMET01257 | DBMET01256 | |
| 0.127 | 0.2 | 0.167 | Cyclic AMP phosphodiesterase inhibitor | 0.167 0.126 DBMET01257 | DBMET01257 | |
| 0.066 | 0.139 | 0.087 | Interleukin 1 beta converting enzyme inhibitor | 0.087 0.077 DBMET01256 | DBMET01256 | |
| 0.008 | 0.085 | 0.024 | Retinoid X beta receptor agonist | 0.024 0.012 DBMET01257 | DBMET01257 | |
| 0.019 | 0.099 | 0.041 | Angiotensin AT1 receptor antagonist | 0.041 0.032 DBMET01257 | DBMET01257 | |
| 0.035 | 0.116 | 0.074 | Leukotriene synthesis inhibitor | 0.074 0.041 DBMET00143 0.063 0.051 DBMET01256 | DBMET00143 | |
| 0.036 | 0.121 | 0.125 | Histidine decarboxylase inhibitor | 0.093 0.035 DBMET00143 0.125 0.024 DBMET01256 0.119 0.026 DBMET01257 | DBMET01256 | |
| 0.029 | 0.115 | 0.073 | Aconitate hydratase inhibitor | 0.073 0.017 DBMET01257 | DBMET01257 | |
| 0.018 | 0.105 | 0.051 | Ribonucleoside-diphosphate reductase inhibitor | 0.051 0.04 DBMET01256 | DBMET01256 | |
| 0.018 | 0.104 | 0.051 | Ribonucleotide reductase inhibitor | 0.051 0.041 DBMET01256 | DBMET01256 | |
| 0.008 | 0.095 | 0.026 | Retinoid X gamma receptor agonist | 0.026 0.013 DBMET01257 | DBMET01257 | |
| 0.053 | 0.142 | 0.108 | Protease inhibitor | 0.087 0.078 DBMET00142 0.108 0.059 DBMET01256 | DBMET01256 | |
| 0.054 | 0.144 | 0.091 | HIV-1 integrase (Overall Integration) inhibitor | 0.091 0.064 DBMET00143 0.081 0.077 DBMET01256 | DBMET00143 | |
| 0.231 | 0.322 | 0.271 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.271 0.254 DBMET00142 | DBMET00142 | |
| 0.049 | 0.141 | 0.086 | Keratolytic | 0.086 0.041 DBMET01257 | DBMET01257 | |
| 0.033 | 0.127 | 0.051 | Thromboxane synthase inhibitor | 0.051 0.044 DBMET01257 | DBMET01257 | |
| 0.024 | 0.118 | 0.062 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.032 DBMET01257 | DBMET01257 | |
| 0.098 | 0.197 | 0.149 | Hepatoprotectant | 0.149 0.111 DBMET00143 0.145 0.116 DBMET01256 0.138 0.123 DBMET01257 | DBMET00143 | |
| 0.012 | 0.113 | 0.037 | NMDA 2D receptor antagonist | 0.037 0.011 DBMET01257 | DBMET01257 | |
| 0.026 | 0.13 | 0.043 | Glutamate (mGluR4) antagonist | 0.043 0.032 DBMET01257 | DBMET01257 | |
| 0.064 | 0.169 | 0.109 | Nav1.4 sodium channel blocker | 0.092 0.089 DBMET00142 0.109 0.064 DBMET01256 | DBMET01256 | |
| 0.082 | 0.191 | 0.158 | Phospholipase A2 inhibitor | 0.158 0.067 DBMET01257 | DBMET01257 | |
| 0.069 | 0.178 | 0.11 | Cyclooxygenase 3 inhibitor | 0.11 0.089 DBMET01257 | DBMET01257 | |
| 0.033 | 0.143 | 0.054 | Sphingosine kinase inhibitor | 0.054 0.052 DBMET01256 | DBMET01256 | |
| 0.06 | 0.17 | 0.113 | Electrolyte absorption antagonist | 0.113 0.042 DBMET01257 | DBMET01257 | |
| 0.023 | 0.134 | 0.079 | Alcohol oxidase inhibitor | 0.079 0.024 DBMET01257 | DBMET01257 | |
| 0.015 | 0.128 | 0.045 | Antimetabolite | 0.045 0.035 DBMET01256 | DBMET01256 | |
| 0.077 | 0.191 | 0.211 | Angiogenesis stimulant | 0.163 0.115 DBMET00143 0.211 0.089 DBMET01256 | DBMET01256 | |
| 0.12 | 0.235 | 0.219 | Hypoglycemic | 0.195 0.117 DBMET00143 0.219 0.097 DBMET01256 0.185 0.128 DBMET01257 | DBMET01256 | |
| 0.098 | 0.213 | 0.158 | Hypolipemic | 0.148 0.139 DBMET01256 0.158 0.128 DBMET01257 | DBMET01257 | |
| 0.073 | 0.188 | 0.117 | Factor V inhibitor | 0.117 0.042 DBMET00142 0.115 0.044 DBMET01256 0.095 0.081 DBMET01257 | DBMET00142 | |
| 0.012 | 0.131 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.02 DBMET01257 | DBMET01257 | |
| 0.034 | 0.156 | 0.061 | Heat shock protein 90 beta antagonist | 0.061 0.038 DBMET00142 | DBMET00142 | |
| 0.022 | 0.143 | 0.082 | Neuraminidase inhibitor | 0.082 0.024 DBMET01257 | DBMET01257 | |
| 0.039 | 0.162 | 0.061 | Potassium channel large-conductance Ca-activated activator | 0.061 0.058 DBMET01257 | DBMET01257 | |
| 0.129 | 0.254 | 0.217 | DNA synthesis inhibitor | 0.174 0.162 DBMET00142 0.174 0.162 DBMET00143 0.217 0.098 DBMET01256 0.198 0.126 DBMET01257 | DBMET01256 | |
| 0.149 | 0.276 | 0.243 | Antiobesity | 0.204 0.203 DBMET00143 0.243 0.163 DBMET01256 | DBMET01256 | |
| 0.064 | 0.193 | 0.107 | Adenylate kinase inhibitor | 0.107 0.057 DBMET01257 | DBMET01257 | |
| 0.045 | 0.177 | 0.061 | Prolactin release inhibitor | 0.061 0.05 DBMET00143 | DBMET00143 | |
| 0.062 | 0.195 | 0.123 | Glutamate release inhibitor | 0.09 0.062 DBMET00142 0.123 0.02 DBMET01256 | DBMET01256 | |
| 0.088 | 0.224 | 0.149 | Insulin sensitizer | 0.149 0.135 DBMET01257 | DBMET01257 | |
| 0.072 | 0.21 | 0.12 | Anticoagulant | 0.12 0.112 DBMET01256 | DBMET01256 | |
| 0.031 | 0.171 | 0.052 | Factor III inhibitor | 0.052 0.029 DBMET01257 | DBMET01257 | |
| 0.039 | 0.185 | 0.119 | Protein-tyrosine phosphatase 1B inhibitor | 0.119 0.064 DBMET01257 | DBMET01257 | |
| 0.087 | 0.234 | 0.243 | Interleukin agonist | 0.193 0.128 DBMET00143 0.243 0.084 DBMET01256 0.196 0.124 DBMET01257 | DBMET01256 | |
| 0.039 | 0.188 | 0.091 | Alcohol dehydrogenase inhibitor | 0.091 0.063 DBMET01257 | DBMET01257 | |
| 0.047 | 0.198 | 0.094 | Ferrochelatase inhibitor | 0.094 0.077 DBMET01257 | DBMET01257 | |
| 0.005 | 0.162 | 0.019 | Retinoic acid alpha receptor antagonist | 0.019 0.016 DBMET01257 | DBMET01257 | |
| 0.065 | 0.225 | 0.164 | Protein-tyrosine phosphatase inhibitor | 0.164 0.067 DBMET01257 | DBMET01257 | |
| 0.01 | 0.178 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.016 DBMET01257 | DBMET01257 | |
| 0.023 | 0.2 | 0.067 | Lipase inhibitor | 0.067 0.058 DBMET01256 | DBMET01256 | |
| 0.06 | 0.259 | 0.122 | Histone deacetylase SIRT1 inhibitor | 0.122 0.089 DBMET01256 | DBMET01256 | |
| 0.013 | 0.221 | 0.047 | Retinoic acid alpha receptor agonist | 0.047 0.017 DBMET01257 | DBMET01257 | |
| 0.048 | 0.256 | 0.082 | Transcription factor NF kappa B stimulant | 0.079 0.073 DBMET00143 0.082 0.066 DBMET01256 | DBMET01256 | |
| 0.128 | 0.338 | 0.241 | Antibacterial | 0.241 0.186 DBMET01257 | DBMET01257 | |
| 0.007 | 0.23 | 0.019 | Retinoic acid beta receptor agonist | 0.019 0.016 DBMET01257 | DBMET01257 | |
| 0.077 | 0.357 | 0.153 | Lipocortins synthesis antagonist | 0.153 0.1 DBMET01257 | DBMET01257 | |
| 0.013 | 0.367 | 0.072 | Myc inhibitor | 0.072 0.017 DBMET00142 0.067 0.021 DBMET01256 | DBMET00142 | |
| 0.059 | 0.602 | 0.242 | Cyclophilin D inhibitor | 0.242 0.222 DBMET01256 | DBMET01256 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |